ANAlexandre Eduardo Nowill

Alexandre Eduardo Nowill

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alexandre Eduardo Nowill has a total of 132 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    T-cell immunity to SARS-CoV-2: what if the known best is not the optimal course for the long run? Adapting to evolving targets

    by Alexandre E. Nowill, Manuel Caruso, Pedro O. de Campos-Lima

    Humanity did surprisingly well so far, considering how unprepared it was to respond to the coronavirus disease 2019 (COVID-19) threat. By blending old and ingenious new technology in the context of the accumulated knowledge on other human coronaviruses, several vaccine candidates were produced and tested in clinical trials in record time. Today, five vaccines account for the bulk of the more than 13 billion doses administered worldwide. The ability to elicit biding and neutralizing antibodies most often against the spike protein is a major component of the protection conferred by immunization but alone it is not enough to limit virus transmission. Thus, the surge in numbers of infected individuals by newer variants of concern (VOCs) was not accompanied by a proportional increase in severe disease and death rate. This is likely due to antiviral T-cell responses, whose evasion is more difficult to achieve. The present review helps navigating the very large literature on T cell immunity induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and vaccination. We examine the successes and shortcomings of the vaccinal protection in the light of the emergence of VOCs with breakthrough potential. SARS-CoV-2 and human beings will likely coexist for a long while: it will be necessary to update existing vaccines to improve T-cell responses and attain better protection against COVID-19.


  • Immune Response Resetting as a Novel Strategy to Overcome SARS-CoV-2–Induced Cytokine Storm

    by Alexandre E Nowill, Pedro O de Campos-Lima

    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19), which rapidly became a pandemic of global proportions. Sepsis is commonly present with high lethality in the severe forms of the disease. The virus-induced cytokine storm puts the immune system in overdrive at the expense of the pathogen-specific immune response and is likely to underlie the most advanced COVID-19 clinical features, including sepsis-related multiple organ dysfunction as well as the pathophysiological changes found in the lungs. We review the major therapeutic strategies that have been considered for sepsis and might be amenable to repurposing for COVID-19. We also discuss two different immunization strategies that have the potential to confer antiviral heterologous protection: innate-induced trained immunity and adaptive-induced immune response resetting.


  • Immune Response Resetting in Ongoing Sepsis

    by Alexandre E. Nowill, Márcia C. Fornazin, Maria C. Spago, Vicente Dorgan Neto, Vitória R. P. Pinheiro, Simônia S. S. Alexandre, Edgar O. Moraes, Gustavo H. M. F. Souza, Marcos N. Eberlin, Lygia A. Marques, et al.

    Cure of severe infections, sepsis, and septic shock with antimicrobial drugs is a challenge because morbidity and mortality in these conditions are essentially caused by improper immune response. We have tested the hypothesis that repeated reactivation of established memory to pathogens may reset unfavorable immune responses. We have chosen for this purpose a highly stringent mouse model of polymicrobial sepsis by cecum ligation and puncture. Five weeks after priming with a diverse Ag pool, high-grade sepsis was induced in C57BL/6j mice that was lethal in 24 h if left untreated. Antimicrobial drug (imipenem) alone rescued 9.7% of the animals from death, but >5-fold higher cure rate could be achieved by combining imipenem and two rechallenges with the Ag pool (p < 0.0001). Antigenic stimulation fine-tuned the immune response in sepsis by contracting the total CD3+ T cell compartment in the spleen and disengaging the hyperactivation state in the memory T subsets, most notably CD8+ T cells, while preserving the recovery of naive subsets. Quantitative proteomics/lipidomics analyses revealed that the combined treatment reverted the molecular signature of sepsis for cytokine storm, and deregulated inflammatory reaction and proapoptotic environment, as well as the lysophosphatidylcholine/phosphatidylcholine ratio. Our results showed the feasibility of resetting uncontrolled hyperinflammatory reactions into ordered hypoinflammatory responses by memory reactivation, thereby reducing morbidity and mortality in antibiotic-treated sepsis. This beneficial effect was not dependent on the generation of a pathogen-driven immune response itself but rather on the reactivation of memory to a diverse Ag pool that modulates the ongoing response.


  • ¿Hay lugar para la cuantificación de la población de células uroteliales luminales basales?

    by G.R. Passos, J.A. Camargo, K.L. Ferrari, G.C. Franch, A.E. Nowill, L.O. Reis

  • Open Access

    Phenotypic and Functional Characterization of NK Cells in Human Immune Response against the Dimorphic Fungus Paracoccidioides brasiliensis

    by Larissa N A Longhi, Rosiane M da Silva, Márcia C Fornazim, Maria C Spago, Rômulo T D de Oliveira, Alexandre E Nowill, Maria H S L Blotta, Ronei L Mamoni

    T cell-driven B cell hyperactivity plays an essential role in driving autoimmune disease development in systemic lupus erythematosus. IL-21 is a member of the type I cytokine family with pleiotropic activities. It regulates B cell differentiation and function, promotes T follicular helper (TFH) cell and Th17 cell differentiation, and downregulates the induction of T regulatory cells. Although IL-21 has been implicated in systemic lupus erythematosus, the relative importance of IL-21R signaling in CD4+ T cells versus B cells is not clear. To address this question, we took advantage of two induced models of lupus-like chronic graft-versus-host disease by using wild-type or IL-21R−/− mice as donors in the parent-into-F1 model and as hosts in the Bm12→B6 model. We show that IL-21R expression on donor CD4+ T cells is essential for sustaining TFH cell number and subsequent help for B cells, resulting in autoantibody production and more severe lupus-like renal disease, but it does not alter the balance of Th17 cells and regulatory T cells. In contrast, IL-21R signaling on B cells is critical for the induction and maintenance of germinal centers, plasma cell differentiation, autoantibody production, and the development of renal disease. These results demonstrate that IL-21 promotes autoimmunity in chronic graft-versus-host disease through both CD4+ T cell- and B cell-intrinsic mechanisms and suggest that IL-21 blockade may attenuate B cell hyperactivity, as well as the aberrant TFH cell pathway that contributes to lupus pathogenesis.


  • Open Access

    Comparison of Effects of the Ethanolic Extracts of Brazilian Propolis on Human Leukemic Cells As Assessed with the MTT Assay

    by Gilberto C. Franchi, Cleber S. Moraes, Viviane C. Toreti, Andreas Daugsch, Alexandre E. Nowill, Yong K. Park

    Propolis is a resinous product collected by honey bees. It was also reported that propolis has a wide variety of biological actions, including antimicrobial activity and antioxidant, anti-inflammatory, and suppressive effects of dioxin toxicity activities. The aim of this study was to compare the in vitro cytotoxic activities of green propolis (G12) and red propolis (G13) in human leukemia cells. These cells were incubated with different concentrations of propolis and 48 hours after the IC50was calculated for each cell. The results showed that the red propolis has cytotoxic effect in vitro higher than green propolis. Red propolis was showed to be cytostatic in K562 cells and caused the same amount of apoptosis as its control Gleevec. In conclusion, these results showed that red propolis is more cytotoxic than the green propolis in a variety of human cell lines of leukemia. Red propolis may contain drugs capable of inhibiting cancer cell growth. Therefore, further isolation of respective chemical ingredients from the red propolis (G13) for identification of the activities is necessary.


  • Preparation and characterisation of 5-fluorouracil containing PLGA nanospheres coated with chitosan, for drug delivery

    by Adriana Calderini, Francisco B.T. Pessine, Gilberto C. Franchi, Alexandre E. Nowill

    The aim of this study was to design a new Drug Delivery System (DDS) based on poly (lactide-co-glycolide) (PLGA) biodegradable nanospheres (NS) coated with Chitosan (CTS), in order to prolong its residence time and to deliver the nanoparticles more specifically to cancer cells. We have tried three methods of incorporation of Chitosan in the nanoparticles, but only one was efficient. The first method is named entanglement of chains, the second method is known as single adsorption and, in the third, we prior linked covalently Chitosan to the polymer and then prepared the nanoparticles. After selected the best method, it was monitored the stability following the temporal variation of diameter, polydispersity and zeta potential of particles prepared using different percentages of CTS and pH values, using a pre-optimised formulation of 5-fluorouracil containing PLGA NS.


  • IGFBP7 participates in the reciprocal interaction between acute lymphoblastic leukemia and BM stromal cells and in leukemia resistance to asparaginase

    by A B A Laranjeira, J F de Vasconcellos, L Sodek, M C Spago, M C Fornazim, L G Tone, S R Brandalise, A E Nowill, J A Yunes

    Leukemia is one of the leading journals in hematology and oncology. It is published monthly and covers all aspects of the research and treatment of leukemia and allied diseases. Studies of normal hemopoiesis are covered because of their comparative relevance.


  • Essential Oil from the Leaves ofCampomanesia guaviroba(DC.) Kiaersk. (Myrtaceae): Chemical Composition, Antioxidant and Cytotoxic Activity

    by Aislan C. R. F. Pascoal, Caroline C. Lourenço, Ladaslav Sodek, Jorge Y. Tamashiro, Gilberto C. Franchi, Alexandre E. Nowill, Maria Élida A. Stefanello, Marcos José Salvador

    The essential oil from the leaves of Campomanesia guaviroba (DC.) Kiaersk., obtained by hydrodistillation, was analyzed by GC and GC/MS. Sixteen compounds could be identified, representing around 94% of the total oil. The major components were myrtenal (27.0%), myrtenol (24.7%) and trans-pinocarveol (15.7%). The essential oil was also evaluated for DPPH radical-scavenging activity by TLC autographic assay, antioxidant capacity by ORAC-FL assay and antiproliferative activity against leukemic cells lines.


  • The Wnt signaling pathway regulates Nalm-16 b-cell precursor acute lymphoblastic leukemic cell line survival and etoposide resistance

    by L.S. Thiago, E.S. Costa, D.V. Lopes, I.B. Otazu, A.E. Nowill, F.A. Mendes, D.M. Portilho, J.G. Abreu, C.S. Mermelstein, A. Orfao, et al.